Home›People›Sam Globus
Sam Globus

Sam Globus

Chief Operating Officer at Genomenon.

Executive
Updated Nov 9, 2026·Latest SEC filing Jul 30, 2026·Suggest an edit

About Sam Globus

Sam Globus is a chief operating officer at Genomenon.

Sam Globus first appears on SEC filings in 2024.

Experience

This experience comes from Sam Globus's profile and from SEC filings. For roles taken from filings, the years are when the filings name Sam Globus in the role, so the role may have started earlier or lasted longer.

Genomenon, Inc. Current
Chief Operating Officer
2022 – Present · Ann Arbor, MI
Genomenon sells genetic evidence software and services to clinical labs and drug developers.
Eagle Genomics Ltd.
VP, Strategy & Operations
2020 – 2022
Celmatix
Vice President, Business Strategy & Operations
2014 – 2019
Bionest Partners
Associate Consultant
2013 – 2014
Memorial Sloan-Kettering Cancer Center
Graduate Student
2005 – 2013
Weill Cornell Medical College
Graduate Student
2005 – 2013
Genitope
Research Associate
2001 – 2003

Key Colleagues at Startups

The people Sam Globus works with at each company, as listed on that company's latest Form D.

Genomenon, Inc. · Form D, Jul 30, 2026
MG
DG
Michael Klein
Michael Klein
Chief Executive Officer and director
Mark Kiel
Mark Kiel
Chief Scientific Officer & Co-Founder, director
PG
Brian Groark
Brian Groark
Chief Financial Officer

Sources

  1. SECGenomenon, Inc. Form D, filed Jul 30, 2026